We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The House of Representatives voted Thursday to repeal the controversial 2.3 percent medical device excise tax, but Democrats and others doubted the effort will get traction in the Senate. Read More
Manufacturers and importers of drug-eluting stents for the Indian market are coming under fire for allegedly conniving with distributors, to hike prices and, in some cases, bribe doctors to use their products. Read More
International device regulators laid out their agenda for the next two years, with plans to finalize a regulatory framework for software as a medical device and guidance on international sharing of adverse event data in 2015. Read More
Devicemakers will have 13 new product-specific guides by the end of the year to tell them what quality-related metrics FDA investigators will focus on during site inspections, agency officials said Tuesday. Read More
When preparing 510(k) submissions, devicemakers should never forget that the “devil is in the details,” a regulatory adviser says. Companies would do well to have a second set of eyes review the submission after any work or changes to guard against mistakes. Read More
The FDA has withdrawn a proposed rule reclassifying external pacemaker pulse generators from Class III to Class II and is now issuing a proposed order to make the reclassification. Read More